These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28861778)

  • 1. Purification and Fibrillation of Full-Length Recombinant PrP.
    Makarava N; Savtchenko R; Baskakov IV
    Methods Mol Biol; 2017; 1658():3-22. PubMed ID: 28861778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and fibrillation of full-length recombinant PrP.
    Makarava N; Baskakov IV
    Methods Mol Biol; 2012; 849():33-52. PubMed ID: 22528082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of Prion Protein Structure Using Nuclear Magnetic Resonance Spectroscopy.
    Biljan I; Ilc G; Plavec J
    Methods Mol Biol; 2017; 1658():35-49. PubMed ID: 28861781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and purification of full-length recombinant PrP of high purity.
    Makarava N; Baskakov IV
    Methods Mol Biol; 2008; 459():131-43. PubMed ID: 18576153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Level Production of High-Purity Human and Murine Recombinant Prion Proteins Functionally Compatible to In Vitro Seeding Assay.
    Hwang HG; Kim DH; Lee J; Mo Y; Lee SH; Lee Y; Hyeon JW; Lee SM; Cheon YP; Choi EK; Kim SY; Lee YS; Son YJ; Ryou C
    J Microbiol Biotechnol; 2018 Oct; 28(10):1749-1759. PubMed ID: 30196595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for conversion of prion protein into amyloid fibrils.
    Breydo L; Makarava N; Baskakov IV
    Methods Mol Biol; 2008; 459():105-15. PubMed ID: 18576151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds.
    Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS
    Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple affinity purification of a baculovirus-derived recombinant prion protein with in vitro ability to convert to its pathogenic form.
    Imamura M; Kato N; Iwamaru Y; Mohri S; Yokoyama T; Murayama Y
    Prep Biochem Biotechnol; 2017 Jan; 47(1):1-7. PubMed ID: 26918377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a new infectious recombinant prion: a model to understand Gerstmann-Sträussler-Scheinker syndrome.
    Elezgarai SR; Fernández-Borges N; Eraña H; Sevillano AM; Charco JM; Harrathi C; Saá P; Gil D; Kong Q; Requena JR; Andréoletti O; Castilla J
    Sci Rep; 2017 Aug; 7(1):9584. PubMed ID: 28851967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A valine-to-lysine substitution at position 210 induces structural conversion of prion protein into a β-sheet rich oligomer.
    Kakuda K; Yamaguchi KI; Kuwata K; Honda R
    Biochem Biophys Res Commun; 2018 Nov; 506(1):81-86. PubMed ID: 30336980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved high-yield expression, purification and refolding of recombinant mammalian prion proteins under aerosol-free elevated biological safety conditions.
    Rehbein P; Schwalbe H
    Protein Expr Purif; 2018 Oct; 150():53-60. PubMed ID: 29751084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid fibrils from the N-terminal prion protein fragment are infectious.
    Choi JK; Cali I; Surewicz K; Kong Q; Gambetti P; Surewicz WK
    Proc Natl Acad Sci U S A; 2016 Nov; 113(48):13851-13856. PubMed ID: 27849581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
    Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and Refolding to Amyloid Fibrils of (His)6-tagged Recombinant Shadoo Protein Expressed as Inclusion Bodies in E. coli.
    Li Q; Richard CA; Moudjou M; Vidic J
    J Vis Exp; 2015 Dec; (106):e53432. PubMed ID: 26709825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid formation by recombinant full-length prion proteins in phospholipid bicelle solutions.
    Lührs T; Zahn R; Wüthrich K
    J Mol Biol; 2006 Mar; 357(3):833-41. PubMed ID: 16466741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PrP P102L and Nearby Lysine Mutations Promote Spontaneous
    Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimized overproduction, purification, characterization and high-pressure sensitivity of the prion protein in the native (PrP(C)-like) or amyloid (PrP(Sc)-like) conformation.
    Alvarez-Martinez MT; Torrent J; Lange R; Verdier JM; Balny C; Liautard JP
    Biochim Biophys Acta; 2003 Feb; 1645(2):228-40. PubMed ID: 12573253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity.
    Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T
    OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-reducing alkaline solubilization and rapid on-column refolding of recombinant prion protein.
    Walsh DJ; Noble GP; Piro JR; Supattapone S
    Prep Biochem Biotechnol; 2012; 42(1):77-86. PubMed ID: 22239709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generating recombinant C-terminal prion protein fragments of exact native sequence.
    Johanssen VA; Barnham KJ; Masters CL; Hill AF; Collins SJ
    Neurochem Int; 2012 Feb; 60(3):318-26. PubMed ID: 22197912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.